MeSH term
Frequency | Condition_Probility | Animals | 15 | 0.0 |
Humans | 54 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Mice | 13 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Rats | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Base Sequence | 18 | 0.0 |
Binding, Competitive | 2 | 0.0 |
DNA Primers | 6 | 0.0 |
DNA-Binding Proteins/*metabolism | 7 | 0.0 |
Phosphoproteins/*metabolism | 4 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Hela Cells | 3 | 0.0 |
Transfection | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Cell Differentiation/*genetics | 2 | 2.0 |
Tumor Cells, Cultured | 9 | 0.0 |
HLA Antigens/*genetics/metabolism | 2 | 16.0 |
Histocompatibility Antigens Class I/*genetics/metabolism | 2 | 10.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Interferon Type II/metabolism | 3 | 1.0 |
Phosphorylation | 8 | 0.0 |
Protein Binding | 8 | 0.0 |
Trans-Activators/*metabolism | 6 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Adult | 8 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 8 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Middle Aged | 8 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
*Repressor Proteins | 7 | 0.0 |
*Transcription Factors | 5 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Cell Line | 7 | 0.0 |
Mutation | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
3T3 Cells | 3 | 0.0 |
Drug Synergism | 3 | 0.0 |
Adolescent | 3 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 8 | 0.0 |
Infant | 2 | 0.0 |
Phosphoproteins/*genetics | 8 | 3.0 |
Polymorphism, Genetic | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
*Cysteine Endopeptidases | 2 | 4.0 |
Case-Control Studies | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Male | 6 | 0.0 |
English Abstract | 2 | 0.0 |
Interferon Type II/pharmacology | 4 | 0.0 |
Interferon-alpha/pharmacology | 3 | 3.0 |
Jurkat Cells | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid | 4 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
Binding Sites | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
HL-60 Cells | 2 | 0.0 |
Apoptosis/*drug effects | 3 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Protein p53/genetics/metabolism | 2 | 2.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Interferon Type II/*pharmacology | 3 | 0.0 |
Membrane Glycoproteins/biosynthesis/*genetics | 2 | 6.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
HMGA1a Protein | 2 | 11.0 |
Brazil | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Pedigree | 3 | 0.0 |
Phenotype | 3 | 0.0 |
*Genes, Regulator | 2 | 1.0 |
Gene Expression/drug effects | 2 | 0.0 |
Interferon-alpha/*pharmacology | 4 | 2.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Phosphoproteins/metabolism | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Gene Expression Regulation, Enzymologic/drug effects | 2 | 1.0 |
Drug Resistance/genetics | 2 | 1.0 |
Tryptophan Oxygenase/*genetics | 2 | 25.0 |
*Chromosomes, Human, Pair 5 | 3 | 1.0 |
Gene Frequency | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
